These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20420965)
1. Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. Mascitti KB; Gerber JS; Zaoutis TE; Barton TD; Lautenbach E Am J Infect Control; 2010 May; 38(4):324-8. PubMed ID: 20420965 [TBL] [Abstract][Full Text] [Related]
2. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713 [TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Hyun DY; Mason EO; Forbes A; Kaplan SL Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459 [TBL] [Abstract][Full Text] [Related]
5. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
6. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center. Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235 [TBL] [Abstract][Full Text] [Related]
7. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. Meddles-Torres C; Hu S; Jurgens C J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin. Barnes EV; Dooley DP; Hepburn MJ; Baum SE Mil Med; 2006 Jun; 171(6):504-7. PubMed ID: 16808130 [TBL] [Abstract][Full Text] [Related]
9. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. De Angelis G; Cipriani M; Cauda R; Tacconelli E Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490 [No Abstract] [Full Text] [Related]
10. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Creech CB; Beekmann SE; Chen Y; Polgreen PM Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924 [TBL] [Abstract][Full Text] [Related]
11. Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014. Klein EY; Mojica N; Jiang W; Cosgrove SE; Septimus E; Morgan DJ; Laxminarayan R Clin Infect Dis; 2017 Nov; 65(11):1921-1923. PubMed ID: 29020322 [TBL] [Abstract][Full Text] [Related]
12. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Cunha BA Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085 [TBL] [Abstract][Full Text] [Related]
13. Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK. Enoch DA; Karas JA; Aliyu SH Int J Antimicrob Agents; 2009 Jun; 33(6):497-502. PubMed ID: 19101123 [TBL] [Abstract][Full Text] [Related]
14. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience. Matiz C; Tom WL; Eichenfield LF; Pong A; Friedlander SF Pediatr Dermatol; 2011; 28(1):6-11. PubMed ID: 21070347 [TBL] [Abstract][Full Text] [Related]
15. Invasive community-associated MRSA infections: epidemiology and antimicrobial management. Pichereau S; Rose WE Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116 [TBL] [Abstract][Full Text] [Related]
16. Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections. Stein M; Komerska J; Prizade M; Sheinberg B; Tasher D; Somekh E Int J Infect Dis; 2016 May; 46():18-21. PubMed ID: 26987479 [TBL] [Abstract][Full Text] [Related]
17. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy. Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483 [TBL] [Abstract][Full Text] [Related]
18. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. Frei CR; Makos BR; Daniels KR; Oramasionwu CU J Pediatr Surg; 2010 Oct; 45(10):1967-74. PubMed ID: 20920714 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic options for treating community-acquired MRSA. Powell JP; Wenzel RP Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495 [TBL] [Abstract][Full Text] [Related]